NCT04305691 2026-02-27
Trial of Ixazomib for Kaposi Sarcoma
AIDS Malignancy Consortium
Phase 2 Recruiting
Clinical Trials
11 trialsNCT05411237 2026-01-23
Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma
AIDS Malignancy Consortium
Phase 3 Not yet recruiting
NCT05797662 2026-01-23
A Study of Propranolol to Treat Kaposi Sarcoma
AIDS Malignancy Consortium
Phase 2 Not yet recruiting
NCT03077451 2025-12-17
Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma
AIDS Malignancy Consortium
Phase 2 Completed
NCT00003008 2023-06-15
Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT01352117 2019-11-14
REACT-KS
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Phase 3 Completed
NCT00686842 2018-06-06
PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma
AIDS Malignancy Consortium
Phase 1/2 Terminated
NCT02137564 2015-07-23
Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma
AIDS Malignancy Consortium
Phase 2 Withdrawn
NCT00427414 2015-04-29
Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma
AIDS Malignancy Consortium
Phase 1 Terminated
NCT00075777 2014-08-29
Valproic Acid in Treating Patients With Kaposi's Sarcoma
AIDS Malignancy Consortium
Phase NA Completed
NCT00450320 2014-08-29
Sirolimus in Treating Patients With HIV-Related Kaposi's Sarcoma
AIDS Malignancy Consortium
Phase 1 Completed